» Articles » PMID: 27813436

Pharmacometrics-based Decision Tools Facilitate MHealth Implementation

Overview
Specialty Pharmacology
Date 2016 Nov 5
PMID 27813436
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The healthcare system is experiencing a paradigm shift in delivering its services, evolving from a reactive 'one size-fits-all' structure to a patient-centric model focusing on individualized medicine. This change is driven by scientific progress, including quantitative evaluation and optimization of treatment strategies through pharmacometric approaches, harnessing the power of the digital revolution. Areas covered: This review describes four main steps to apply pharmacometrics-based decision support tools, consisting of validated scientific components, available technical options, consideration of regulatory aspects, and achievement of efficient commercialization. Examples of pharmacometrics-based decision tools that support monitoring of patients and individualization of treatment strategies in neonates, children and adults are presented. Expert commentary: We envision that user-friendly decision support tools will facilitate implementation of mobile health approaches (mHealth) realizing benefits to paediatric and adult patients and their caregivers.

Citing Articles

Clinically practical pharmacometrics computer model to evaluate and personalize pharmacotherapy in pediatric rare diseases: application to Graves' disease.

Steffens B, Koch G, Gachter P, Claude F, Gotta V, Bachmann F Front Med (Lausanne). 2023; 10:1099470.

PMID: 37206476 PMC: 10188966. DOI: 10.3389/fmed.2023.1099470.


Leveraging Predictive Pharmacometrics-Based Algorithms to Enhance Perinatal Care-Application to Neonatal Jaundice.

Koch G, Wilbaux M, Kasser S, Schumacher K, Steffens B, Wellmann S Front Pharmacol. 2022; 13:842548.

PMID: 36034866 PMC: 9402995. DOI: 10.3389/fphar.2022.842548.


Pharmacometrics and Machine Learning Partner to Advance Clinical Data Analysis.

Koch G, Pfister M, Daunhawer I, Wilbaux M, Wellmann S, Vogt J Clin Pharmacol Ther. 2020; 107(4):926-933.

PMID: 31930487 PMC: 7158220. DOI: 10.1002/cpt.1774.


Towards Personalized Antithrombotic Treatments: Focus on P2Y Inhibitors and Direct Oral Anticoagulants.

Terrier J, Daali Y, Fontana P, Csajka C, Reny J Clin Pharmacokinet. 2019; 58(12):1517-1532.

PMID: 31250210 DOI: 10.1007/s40262-019-00792-y.